Forskningsradar
← Alla bevakningsområden

Life Sciences

1736 artiklar · sida 49 av 70

🇸🇪 Endast svenska
4.4

Researchers have designed a microscopic trap that captures individual disease-carrying particles from blood and makes them glow brighter, solving a major obstacle to using these particles as reliable diagnostic tools. The advance could accelerate development of blood tests that detect diseases earlier and more accurately than existing methods.EN

2024-01-01 · ACS Omega · , , et al.
4.4

Researchers using patient stem cells discovered that Dravet syndrome—a severe childhood epilepsy—causes abnormal acceleration in brain cell maturation at the genetic level. The finding offers a potential therapeutic pathway: an existing epilepsy drug partially reversed these developmental errors, suggesting a new treatment strategy for a condition that affects thousands of children worldwide.EN

2024-01-01 · eLIFE · , , et al.
4.4

Researchers analyzing 2,550 Swedish breast cancer patients have found a previously unknown genetic risk factor and confirmed three others, suggesting the need to revamp how doctors assess cancer vulnerability. The discovery could reshape genetic testing strategies and personalized medicine approaches for cancer prevention in coming years.EN

2024-01-01 · Genes · , , et al.
4.4

Researchers have engineered a microchip that identifies tiny disease-carrying particles in blood with unprecedented sensitivity, potentially enabling faster disease diagnosis at lower cost. The silicon-based device could accelerate development of point-of-care diagnostic tools for cancer, heart disease, and other conditions where early detection saves lives and reduces treatment expenses.EN

2024-01-01 · ACS Sensors · , , et al.
4.4

Researchers have developed a new class of therapeutic compounds that directly invade and bind to DNA to silence disease-causing genes, demonstrating success against huntingtin—the faulty protein driving Huntington's disease. The advance could expand treatment options for genetic disorders currently lacking effective therapies, opening a significant market opportunity for biotech companies developing precision genetic medicines.EN

2024-01-01 · Molecular Therapy Nucleic Acids · , , et al.
4.4

Patients with severe alpha-1 antitrypsin deficiency—a hereditary disorder affecting roughly 1 in 3,000 people—faced significantly elevated COVID-19 risks during the pandemic, particularly those with concurrent lung disease. The finding could reshape clinical protocols for managing vulnerable populations and inform pharmaceutical development for both genetic lung disorders and respiratory infections.EN

2024-01-01 · The International Journal of Chronic Obstructive Pulmonary Disease · , , et al.
4.4

Researchers tracking Mosul residents after intense urban combat discovered that exposure to severe violence strengthens both individual fairness concerns and group loyalty—challenging assumptions about how trauma fractures societies. The finding has implications for post-conflict reconstruction, humanitarian aid design, and understanding how populations rebuild after mass violence.EN

2024-01-01 · Journal of Conflict Resolution · , ,
4.4

A new study challenges a major barrier to intestinal transplantation: researchers found that donor intestines maintain blood flow and structural integrity even after brain death, despite severe drops in blood pressure. The finding could expand the pool of viable organs for transplant, potentially addressing a critical shortage that forces thousands of patients to remain on life support.EN

2024-01-01 · European Surgical Research · , , et al.
4.4

A new study found that lidocaine, a common seizure treatment in neonatal intensive care units, does not cause lasting behavioral problems in early life exposure. The finding provides reassurance to hospitals and regulators about the safety profile of this widely used drug in premature infants.EN

2024-01-01 · Basic & Clinical Pharmacology & Toxicology · , , et al.
4.4

Researchers have created a new class of cancer drugs that irreversibly disable carbonic anhydrase IX, a protein that helps tumors survive and spread by acidifying their environment. The compounds achieved record-breaking binding strength, potentially opening a faster path to treating solid cancers resistant to existing therapies.EN

2024-01-01 · eLIFE · , , et al.
4.4

Researchers analyzed nearly 100,000 people across Scandinavia and the UK to find genetic factors influencing dog ownership, but discovered only weak genetic signals and no specific genes responsible. The null result suggests pet ownership is driven primarily by social and economic factors rather than inherited biology—important context for pet industry planners and public health researchers studying pet-related interventions.EN

2024-01-01 · G3 · , , et al.
4.4

Swedish researchers tracking 82,000 IBD patients found they develop heart failure at significantly higher rates than the general population, suggesting the gut-inflammation connection extends beyond digestive health. The finding could reshape how doctors monitor and treat IBD patients, opening new market opportunities for diagnostic tools and preventive therapies.EN

2024-01-01 · European Heart Journal · , , et al.
4.4

Researchers have identified the step-by-step process by which liposarcoma tumors accumulate dangerous gene copies through chromosome rearrangement, not the previously thought mechanism. The finding could reshape how scientists understand tumor evolution and potentially inform strategies for early detection and treatment of this common soft-tissue cancer.EN

2024-01-01 · Communications Biology · , , et al.
4.4

Researchers found that toddlers later diagnosed with autism look less frequently at a child's face during social conflict—a difference detectable at 18 months, well before formal diagnosis at age 3. The finding could enable earlier intervention and reduce long-term costs of support services.EN

2024-01-01 · Journal of autism and developmental disorders · , ,
4.4

Researchers identified adults with IL-7 gene mutations who defy expectations by living with severely compromised T cell counts yet avoiding life-threatening infections. The finding suggests the immune system has backup pathways for survival that could inform new therapies for immunodeficiency and potentially cancer immunotherapy strategies.EN

2024-01-01 · Journal of Clinical Investigation · , , et al.
4.4

Researchers found that diagnosing generalized joint hypermobility—a genetic connective tissue disorder—cannot rely on a single standard test or measurement threshold. The finding could reshape clinical guidelines and highlight the need for personalized diagnostic approaches, affecting care protocols and insurance coverage decisions across rheumatology and genetics.EN

2024-01-01 · PLOS ONE · , , et al.
4.4

Researchers analyzed blood chemistry from over 11,000 Swedish adults and found that two-thirds of detectable metabolites appear consistently across populations—a crucial step toward using blood tests for personalized medicine. The findings establish a scientific baseline for diagnostic companies and pharmaceutical firms developing precision health tools.EN

2024-01-01 · Scientific Reports · , , et al.
4.4

Researchers have identified a resurgence of formalist art analysis powered by computational tools—a shift that could reshape how museums, galleries, and cultural institutions organize and study their collections at scale. The trend also reveals how humanistic expertise can improve machine learning systems designed for visual analysis.EN

2023-01-01 ·
4.4

Researchers have pinpointed 19 genetic locations linked to a progressive spinal disorder that leaves pugs paralyzed and incontinent. The discovery opens pathways for breed-specific disease screening and potential therapies—and demonstrates how precision genetics can tackle inherited conditions in animals, with implications for human neurodegenerative disease research.EN

2023-01-01 · Genes · , , et al.
4.4

A genetic study flips the script on obesity: it's not that lazy people gain weight, but that heavier people become more sedentary. More surprisingly, education levels emerged as the underlying factor influencing both exercise habits and body weight. The findings could reshape how public health campaigns and employers approach fitness programs.EN

2023-01-01 · Communications Medicine · , , et al.
4.4

Researchers have mapped how obscure RNA molecules hijack the cancer cell's control switches, reshaping its internal architecture to fuel multiple myeloma. The discovery suggests pharma companies could develop entirely new therapies by targeting these RNA regulators themselves—potentially offering treatment options for a disease that still lacks cures.EN

2023-01-01 · Frontiers in Oncology · , , et al.
4.4

Researchers have identified serious flaws in a 2020 genomics paper that make its findings unreliable, raising questions about peer review in high-impact journals. The discovery underscores growing concerns about reproducibility in genomic research and highlights risks for companies and institutions relying on published genomic studies for product development or clinical decisions.EN

2023-01-01 · BMC Genomics · ,
4.4

Researchers found that infusing acyl ghrelin—a naturally occurring hormone—increased growth hormone levels in heart failure patients with weakened pumping capacity. The finding suggests a potential new therapeutic pathway for a condition affecting millions globally, opening a drug development opportunity in the underserved heart failure market.EN

2023-01-01 · European Journal of Heart Failure · , , et al.
4.4

Researchers identified a single genetic deletion responsible for the rumpless trait in chickens, mapping a novel gene called Rum that controls tail development. The discovery could reshape poultry breeding programs and offers insights into how developmental genes work—potentially informing studies of birth defects across species.EN

2023-01-01 · Molecular biology and evolution · , , et al.
4.4

Researchers found that cheap brightfield microscopy can predict how drugs work just as well as costly fluorescence imaging, potentially cutting screening costs. The discovery uses AI to overcome image quality limits, opening doors to faster, cheaper drug development pipelines and time-lapse studies impossible with traditional methods.EN

2023-01-01 · PloS Computational Biology · , , et al.